Charts Adaptive Biotechnologies Corporation
Stocks
ADPT
US00650F1093
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:00:00 2026-09-16 EDT
|
5-day change | 1st Jan Change | ||
| 27.67 USD | +3.71% |
|
+13.31% | +70.38% |
| 08-20 | Adaptive Biotechnologies Insider Sold Shares Worth $3,135,850, According to a Recent SEC Filing | MT |
| 07-30 | Adaptive Biotechnologies Q2 Loss Widens, Revenue Rise | MT |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ADPT | Delayed | |
CBOE
| ADPT | Real-time | |
Tradegate
| 1HM | Real-time | |
Deutsche Boerse AG
| 1HM | Delayed | |
Börse Stuttgart
| 1HM | Delayed | |
Boerse Muenchen
| 1HM | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 28.64 | 35.34 | 34.54 |
| Spread/Res. | -3.39% | -21.70% | -19.89% |
| Spread/Supp. | +8.72% | +47.73% | +49.16% |
| Support | 25.45 | 18.73 | 18.55 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ADPT Stock
- Charts Adaptive Biotechnologies Corporation
Select your edition
All financial news and data tailored to specific country editions

















